Inhaled Nitric Oxide

The Defense Health Agency intends to sole‑source a contract to INO THERAPEUTICS LLC for the procurement and support of inhaled nitric oxide (iNO) therapy at Brooke Army Medical Center, Fort Sam Houston, Texas. The effort includes supplying the iNO pharmaceutical (800 ppm), a specialized delivery device meeting label specifications, all requisite maintenance, calibration, consumables, and a full suite of services such as training, logistics, and pick‑up/delivery. The period of performance runs from 1 Jan 2027 to 31 Dec 2027 with four optional one‑year extensions. • Supply of nitric oxide drug (800 ppm) for inhalation therapy. • Delivery of a certified iNO delivery system and associated accessories. • Comprehensive support services: training, maintenance, calibration, and logistics. • Option to extend the contract for up to four additional years.